The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells

被引:294
作者
Hesse, M
Piccirillo, CA
Belkaid, Y
Prufer, J
Mentink-Kane, M
Leusink, M
Cheever, AW
Shevach, EM
Wynn, TA
机构
[1] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA
[3] Biomed Res Inst, Rockville, MD 20852 USA
关键词
D O I
10.4049/jimmunol.172.5.3157
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-10 reduces immunopathology in many persistent infections, yet the contribution of IL-10 from distinct cellular sources remains poorly defined. We generated IL-10/recombination-activating gene (RAG)2-deficient mice and dissected the role of T cell- and non-T cell-derived IL-10 in schistosomiasis by performing adoptive transfers. In this study, we show that IL-10 is generated by both the innate and adaptive immune response following infection, with both sources regulating the development of type-2 immunity, immune-mediated pathology, and survival of the infected host. Importantly, most of the CD4(+) T cell-produced IL-10 was confined to a subset of T cells expressing CD25. These cells were isolated from egg-induced granulomas and exhibited potent suppressive activity in vitro. Nevertheless, when naive, naturally occurring CD4(+)CD25(+) cells were depleted in adoptive transfers, recipient IL-10/RAG2-deficient animals were more susceptible than RAG2-deficient mice, confirming an additional host-protective role for non-T cell-derived IL-10. Thus, innate effectors and regulatory T cells producing IL-10 cooperate to reduce morbidity and prolong survival in schistosomiasis.
引用
收藏
页码:3157 / 3166
页数:10
相关论文
共 60 条
[1]   CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 [J].
Annacker, O ;
Pimenta-Araujo, R ;
Burlen-Defranoux, O ;
Barbosa, TC ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3008-3018
[2]   CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity [J].
Belkaid, Y ;
Piccirillo, CA ;
Mendez, S ;
Shevach, EM ;
Sacks, DL .
NATURE, 2002, 420 (6915) :502-507
[3]   MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[4]   Endogenous IL-10 regulates IFN-γ and IL-5 cytokine production and the granulomatous response in Schistosomiasis mansoni-infected mice [J].
Boros, DL ;
Whitfield, JR .
IMMUNOLOGY, 1998, 94 (04) :481-487
[5]   IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni [J].
Bosshardt, SC ;
Freeman, GL ;
Secor, WE ;
Colley, DG .
PARASITE IMMUNOLOGY, 1997, 19 (08) :347-353
[6]  
Brunet LR, 1999, INFECT IMMUN, V67, P3014
[7]  
CHEEVER AW, 1994, J IMMUNOL, V153, P753
[9]   An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response [J].
Chiaramonte, MG ;
Donaldson, DD ;
Cheever, AW ;
Wynn, TA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06) :777-785
[10]   Regulation and function of the interleukin 13 receptor α 2 during a T helper cell type 2-dominant immune response [J].
Chiaramonte, MG ;
Mentink-Kane, M ;
Jacobson, BA ;
Cheever, AW ;
Whitters, MJ ;
Goad, MEP ;
Wong, A ;
Collins, M ;
Donaldson, DD ;
Grusby, MJ ;
Wynn, TA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) :687-701